Business
Manganese X Subsidiary Signs Definitive Agreement for USA Patented PureBiotics HVAC Delivery System for Virus and Bacteria Mitigation
Montreal, Quebec--(Newsfile Corp. - November 16, 2020) - Manganese X Energy Corp. (TSXV: MN) ...
About this update from Manganese X Energy Corp.
[{"type":"text","content":"Manganese X Subsidiary Signs Definitive Agreement for USA Patented PureBiotics HVAC Delivery System for Virus and Bacteria MitigationMontreal, Quebec--(Newsfile Corp. - November 16, 2020) - Manganese X Energy Corp. (TSXV: MN) (FSE: 9SC2) (OTC: MNXXF) (\"Manganese X\" or the \"Company\") announces that Disruptive Battery Corp (\"DBC\"), a wholly owned subsidiary of Manganese X, is pleased to confirm that it has executed a definitive agreement with PureBiotics to acquire a 50% equity stake in PureBiotics, an environmental air quality control company. The manufactured product will be a USA based air quality control delivery system. The environmental air solution will incorporate our US patented disinfection apparatus system, designed to circulate air disinfection agents (ADAs) through a building's HVAC (heating, ventilation and air conditioning) distribution system, as well as provide PureBiotics proprietary proven safe & effective biological solutions for air and surface environmental control for healthier homes and buildings.Martin Kepman, CEO, comments, \"Putting together this JV was a process. Investors have to understand that our HVAC and related air solution is a massive contemplation given the current cycle of human society. Pandemic management and defense is the order of the day and our goal is to get society mobilized again in such a way as to reduce both fear and risk of breathing air in a contained environment. We believe our air management solution is not only relevant but necessary. Further, from a business perspective, we see a scalable product with extreme distribution potential.\"According to the Centers for Disease Control and Prevention, some infections can be spread by exposure to virus in small droplets and particles that can linger in the air for minutes to hours. These viruses may be able to infect people who are farther than six feet away from the person who is infected or after that person has left the space. The Prime objective of this JV is to provide solutions to the healthcare risks associated with the air quality in homes and businesses, including lowering the risk of infections, as well as allergens, contaminants and odors. The modus operandi will be combining 'PureBiotics' existing product lines and technologies with DBC's US patent and other resources of Manganese X.Phase 1 will initiate immediat...